23andMe, Genentech Recruiting Patients for Alzheimer's Genetics Research

"This research could lead to new scientific knowledge or possibly a drug that could prevent or slow [the] disease," 23andMe states in an informational release targeted to customers who may be eligible to participate in an Alzheimer's study it is conducting with biotech partner Genentech.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories